ngt-banner

Customized Solutions for Complex Challenges

NGT BioPharma Consultants Leadership Team

Michael K. O’Brien, PhD
President & CEO
Edward Herpel NGT BioPharma Consultants
Ed Herpel, MA
Senior VP Business Effectiveness
Mark A. Krook, PhD
Head, Early Drug Development

Daniel Schaufelberger, PhD
VP Chemistry, Manufacturing & Controls​
Ronay LeBlanc, MA
VP Quality & Compliance
Michael J. Neeb, PhD
VP Discovery & Investigative Research
 
Michelle McGuinness, MS
Non-CMC Regulatory Strategy
Michael Placke, PhD, DABT
Michael Placke, PhD, DABT
Nonclinical Sciences
Jim Weber, PhD
Strategist CMC Biologics
Roger Nosal, MA
Head of Global Regulatory Strategy and Submissions
Rachel Franckowiak, BA
Senior Director, Administration
Malcolm Berry, PhD - Multi-Stage Continuous Processing for APIs
 
Malcolm Berry, PhD
API Continuous Processing

Nancy C. Motola, PhD, RAC
Regulatory, Compliance, Quality Assurance
Michael Placke, NGT Biopharma Consultants
 
Michael Placke, PhD, DABT
Nonclinical Development
and Drug Safety

Leo Adalbert, NGT BioPharma Consultants

 
Leo J. Adalbert
Principal Consultant –
Strategic Commercialization

 
John L. Dillon, PhD
API Process R&D, Synthetic Organic Chemistry
 
Jeff Brum, PhD
Pharmaceutical Analysis – CMC Product Development

Robert Dennehy, PhD
API Crystallization and Solid State
 
Steve Hammond
Process Analytics and
PAT Innovator
 
Paul E. Luner, PhD
Oral Formulation Development & Physical Pharmaceutics
 
Frank P. Orlowski, MBA
Biotech and Life Sciences
Global Finance
 
Douglas Nesta, PhD
Chemistry, Manufacturing & Controls
 
Mike Webb, PhD
Chemistry, Manufacturing & Controls